An interventional study of Black Doctor Screening Video and White Doctor Screening Video in Prostate Cancer, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-26.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Other
The study team will evaluate the impact of video characteristics on health consumers' trust in online videos. Participants will be randomized to watch a video by one of four speakers about prostate cancer screening or clinical trials and complete a questionnaire (approximately 15 minutes total).
6,484 studies on the registry are indexed under Prostatic Neoplasms; 1,415 are open to participants now.
This study's enrollment of 3,649 is above the median of 58 across 4,908 interventional studies indexed under Prostatic Neoplasms.
Browse Prostatic Neoplasms studies →NYU Langone Health is the lead sponsor of 1,421 studies on the registry; 254 are open to participants now.
Of its 231 completed or terminated interventional studies of FDA-regulated products, 195 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Black Doctor Screening Video
Other: White Doctor Screening Video
Other: Black Patient Screening Video
Other: White Patient Screening Video
Other: Black Doctor Clinical Trials Video
Other: White Doctor Clinical Trials Video
Other: Black Patient Clinical Trials Video
Other: White Patient Clinical Trials Video
Participants will view an online video with a Black doctor speaking about prostate cancer screening.
Participants will view an online video with a White doctor speaking about prostate cancer screening.
Participants will view an online video with a Black patient speaking about prostate cancer screening.
Participants will view an online video with a White patient speaking about prostate cancer screening.
Participants will view an online video with a Black doctor speaking about prostate cancer clinical trials.
Participants will view an online video with a White doctor speaking about prostate cancer clinical trials.
Participants will view an online video with a Black patient speaking about prostate cancer clinical trials.
Participants will view an online video with a White patient speaking about prostate cancer clinical trials.
Level of Trust in the Video
Trust will be reported as a score on a Likert scale and asked as the following question: How much do you trust the information in the video? The total range of score is 1-4, where (1) trust the information completely, (2) trust most of the information, (3) trust some of the information, (4) do not trust the information
Time frame: Visit 1 (Day 1)
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — Individual participant data needed for the proposed biomedical research use according to data use agreement from both parties will be shared.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access criteria: The investigator who proposed to use the data after signing a data use agreement will have access to the data upon reasonable request for biomedical research purposes. Requests should be directed to stacy.loeb@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Ran from Aug 2021 to primary completion in Jan 2022, 4 months.
Of 1,018 non-industry interventional studies with no phase under Prostatic Neoplasms, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 87. This study's 4 months is below that.
Counting every sponsor, half of 1,063 studies reached it within 45 months; a quarter within 22 and three quarters within 87.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.